Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Screening strategies for early detection of lung cancer: the time is now.

JAMA

Petty TL.
PMID: 11035898
JAMA. 2000 Oct 18;284(15):1977-80. doi: 10.1001/jama.284.15.1977.

No abstract available.

Cite
Petty TL. Screening strategies for early detection of lung cancer: the time is now. JAMA. 2000;284(15):1977-80doi: 10.1001/jama.284.15.1977.
Petty, T. L. (2000). Screening strategies for early detection of lung cancer: the time is now. JAMA, 284(15), 1977-80. https://doi.org/10.1001/jama.284.15.1977
Petty, T L. "Screening strategies for early detection of lung cancer: the time is now." JAMA vol. 284,15 (2000): 1977-80. doi: https://doi.org/10.1001/jama.284.15.1977
Petty TL. Screening strategies for early detection of lung cancer: the time is now. JAMA. 2000 Oct 18;284(15):1977-80. doi: 10.1001/jama.284.15.1977. PMID: 11035898.
Copy Download .nbib Format: NLM
What is a reasonable cost to refute a preposterous hypothesis?.

British journal of cancer

Castleberry AW, Grannis FW.
PMID: 20051946
Br J Cancer. 2010 Feb 02;102(3):627-8. doi: 10.1038/sj.bjc.6605523. Epub 2010 Jan 05.

No abstract available.

Cite
Castleberry AW, Grannis FW. What is a reasonable cost to refute a preposterous hypothesis?. Br J Cancer. 2010;102(3):627-8doi: 10.1038/sj.bjc.6605523.
Castleberry, A. W., & Grannis, F. W. (2010). What is a reasonable cost to refute a preposterous hypothesis?. British journal of cancer, 102(3), 627-8. https://doi.org/10.1038/sj.bjc.6605523
Castleberry, A W, and Grannis, F W. "What is a reasonable cost to refute a preposterous hypothesis?." British journal of cancer vol. 102,3 (2010): 627-8. doi: https://doi.org/10.1038/sj.bjc.6605523
Castleberry AW, Grannis FW. What is a reasonable cost to refute a preposterous hypothesis?. Br J Cancer. 2010 Feb 02;102(3):627-8. doi: 10.1038/sj.bjc.6605523. Epub 2010 Jan 05. PMID: 20051946; PMCID: PMC2822951.
Copy Download .nbib Format: NLM
Status of Lung Cancer Data Collection in Europe.

JCO clinical cancer informatics

Rich A, Beckett P, Baldwin D.
PMID: 30652540
JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00052.

No abstract available.

Cite
Rich A, Beckett P, Baldwin D. Status of Lung Cancer Data Collection in Europe. JCO Clin Cancer Inform. 2018;2:1-12doi: 10.1200/CCI.17.00052.
Rich, A., Beckett, P., & Baldwin, D. (2018). Status of Lung Cancer Data Collection in Europe. JCO clinical cancer informatics, 21-12. https://doi.org/10.1200/CCI.17.00052
Rich, Anna, et al. "Status of Lung Cancer Data Collection in Europe." JCO clinical cancer informatics vol. 2 (2018): 1-12. doi: https://doi.org/10.1200/CCI.17.00052
Rich A, Beckett P, Baldwin D. Status of Lung Cancer Data Collection in Europe. JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00052. PMID: 30652540.
Copy Download .nbib Format: NLM
Screening for lung cancer: it's still not worthwhile.

Delaware medical journal

Lally J.
PMID: 8467935
Del Med J. 1993 Apr;65(4):273-4.

No abstract available.

Cite
Lally J. Screening for lung cancer: it's still not worthwhile. Del Med J. 1993;65(4):273-4
Lally, J. (1993). Screening for lung cancer: it's still not worthwhile. Delaware medical journal, 65(4), 273-4.
Lally, J. "Screening for lung cancer: it's still not worthwhile." Delaware medical journal vol. 65,4 (1993): 273-4.
Lally J. Screening for lung cancer: it's still not worthwhile. Del Med J. 1993 Apr;65(4):273-4. PMID: 8467935.
Copy Download .nbib Format: NLM
Evidence of sex and gender differences spurs call for more research funding.

Cancer cytopathology

Nelson B.
PMID: 20731001
Cancer Cytopathol. 2010 Aug 25;118(4):173-4. doi: 10.1002/cncy.20100.

No abstract available.

Cite
Nelson B. Evidence of sex and gender differences spurs call for more research funding. Cancer Cytopathol. 2010;118(4):173-4doi: 10.1002/cncy.20100.
Nelson, B. (2010). Evidence of sex and gender differences spurs call for more research funding. Cancer cytopathology, 118(4), 173-4. https://doi.org/10.1002/cncy.20100
Nelson, Bryn. "Evidence of sex and gender differences spurs call for more research funding." Cancer cytopathology vol. 118,4 (2010): 173-4. doi: https://doi.org/10.1002/cncy.20100
Nelson B. Evidence of sex and gender differences spurs call for more research funding. Cancer Cytopathol. 2010 Aug 25;118(4):173-4. doi: 10.1002/cncy.20100. PMID: 20731001.
Copy Download .nbib Format: NLM
[Disease burden of lung cancer in Jinchang cohort].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Zheng S, Pu H, Dai M, Bai Y, Li H, Chang S, Wang M, Wang Z, Zhu J, Ren X, Li J, Cheng N.
PMID: 27005526
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):311-5. doi: 10.3760/cma.j.issn.0254-6450.2016.03.003.

OBJECTIVE: To understand the current status of lung cancer disease burden in Jinchang cohort.METHODS: In this historical cohort study, the mortality data of the lung cancer from 2001 to 2013 and medical records of the lung cancer cases from...

Cite
Zheng S, Pu H, Dai M, et al. [Disease burden of lung cancer in Jinchang cohort]. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(3):311-5doi: 10.3760/cma.j.issn.0254-6450.2016.03.003.
Zheng, S., Pu, H., Dai, M., Bai, Y., Li, H., Chang, S., Wang, M., Wang, Z., Zhu, J., Ren, X., Li, J., & Cheng, N. (2016). [Disease burden of lung cancer in Jinchang cohort]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 37(3), 311-5. https://doi.org/10.3760/cma.j.issn.0254-6450.2016.03.003
Zheng, Shan, et al. "[Disease burden of lung cancer in Jinchang cohort]." Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 37,3 (2016): 311-5. doi: https://doi.org/10.3760/cma.j.issn.0254-6450.2016.03.003
Zheng S, Pu H, Dai M, Bai Y, Li H, Chang S, Wang M, Wang Z, Zhu J, Ren X, Li J, Cheng N. [Disease burden of lung cancer in Jinchang cohort]. Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):311-5. doi: 10.3760/cma.j.issn.0254-6450.2016.03.003. Chinese. PMID: 27005526.
Copy Download .nbib Format: NLM
Value-Based Care in Lung Cancer.

The oncologist

Eaton KD, Jagels B, Martins RG.
PMID: 27256872
Oncologist. 2016 Aug;21(8):903-6. doi: 10.1634/theoncologist.2016-0116. Epub 2016 Jun 02.

No abstract available.

Cite
Eaton KD, Jagels B, Martins RG. Value-Based Care in Lung Cancer. Oncologist. 2016;21(8):903-6doi: 10.1634/theoncologist.2016-0116.
Eaton, K. D., Jagels, B., & Martins, R. G. (2016). Value-Based Care in Lung Cancer. The oncologist, 21(8), 903-6. https://doi.org/10.1634/theoncologist.2016-0116
Eaton, Keith D, et al. "Value-Based Care in Lung Cancer." The oncologist vol. 21,8 (2016): 903-6. doi: https://doi.org/10.1634/theoncologist.2016-0116
Eaton KD, Jagels B, Martins RG. Value-Based Care in Lung Cancer. Oncologist. 2016 Aug;21(8):903-6. doi: 10.1634/theoncologist.2016-0116. Epub 2016 Jun 02. PMID: 27256872; PMCID: PMC4978558.
Copy Download .nbib Format: NLM
A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients".

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Park J.
PMID: 29785636
Support Care Cancer. 2019 Feb;27(2):329-330. doi: 10.1007/s00520-018-4267-1. Epub 2018 May 21.

No abstract available.

Cite
Park J. A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients". Support Care Cancer. 2018;27(2):329-330doi: 10.1007/s00520-018-4267-1.
Park, J. (2019). A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients". Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 27(2), 329-330. https://doi.org/10.1007/s00520-018-4267-1
Park, Joohyun. "A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients"." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 27,2 (2019): 329-330. doi: https://doi.org/10.1007/s00520-018-4267-1
Park J. A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients". Support Care Cancer. 2019 Feb;27(2):329-330. doi: 10.1007/s00520-018-4267-1. Epub 2018 May 21. PMID: 29785636.
Copy Download .nbib Format: NLM
The barriers to initiating lung cancer care in low-and middle-income countries.

The Pan African medical journal

Lubuzo B, Ginindza T, Hlongwana K.
PMID: 32499854
Pan Afr Med J. 2020 Feb 12;35:38. doi: 10.11604/pamj.2020.35.38.17333. eCollection 2020.

Lung cancer in low-and middle-income countries is the leading and the second leading cause of cancer deaths in males and females, respectively. This, in part, is due to late presentation of patients in health facilities and late diagnosis, thereby...

Cite
Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J. 2020;35:38doi: 10.11604/pamj.2020.35.38.17333.
Lubuzo, B., Ginindza, T., & Hlongwana, K. (2020). The barriers to initiating lung cancer care in low-and middle-income countries. The Pan African medical journal, 3538. https://doi.org/10.11604/pamj.2020.35.38.17333
Lubuzo, Buhle, et al. "The barriers to initiating lung cancer care in low-and middle-income countries." The Pan African medical journal vol. 35 (2020): 38. doi: https://doi.org/10.11604/pamj.2020.35.38.17333
Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J. 2020 Feb 12;35:38. doi: 10.11604/pamj.2020.35.38.17333. eCollection 2020. PMID: 32499854; PMCID: PMC7245978.
Copy Download .nbib Format: NLM
[Informed consent, QOL and cost benefit in the treatment of lung cancer].

Nihon rinsho. Japanese journal of clinical medicine

Kubota K.
PMID: 10824566
Nihon Rinsho. 2000 May;58(5):1153-7.

Ethical issues, including informed consent, quality of life and cost/benefit, are discussed. Informed consent is not only ethical discipline but also legal concept. It is important to know how and when to disclose the truth. Training and experience are...

Cite
Kubota K. [Informed consent, QOL and cost benefit in the treatment of lung cancer]. Nihon Rinsho. 2000;58(5):1153-7
Kubota, K. (2000). [Informed consent, QOL and cost benefit in the treatment of lung cancer]. Nihon rinsho. Japanese journal of clinical medicine, 58(5), 1153-7.
Kubota, K. "[Informed consent, QOL and cost benefit in the treatment of lung cancer]." Nihon rinsho. Japanese journal of clinical medicine vol. 58,5 (2000): 1153-7.
Kubota K. [Informed consent, QOL and cost benefit in the treatment of lung cancer]. Nihon Rinsho. 2000 May;58(5):1153-7. Japanese. PMID: 10824566.
Copy Download .nbib Format: NLM
Lung cancer: some progress, but still a lot more to do.

Lancet (London, England)

The Lancet.
PMID: 31777378
Lancet. 2019 Nov 23;394(10212):1880. doi: 10.1016/S0140-6736(19)32795-3.

No abstract available.

Cite
The Lancet. Lung cancer: some progress, but still a lot more to do. Lancet. 2019;394(10212):1880doi: 10.1016/S0140-6736(19)32795-3.
The Lancet. (2019). Lung cancer: some progress, but still a lot more to do. Lancet (London, England), 394(10212), 1880. https://doi.org/10.1016/S0140-6736(19)32795-3
The Lancet. "Lung cancer: some progress, but still a lot more to do." Lancet (London, England) vol. 394,10212 (2019): 1880. doi: https://doi.org/10.1016/S0140-6736(19)32795-3
The Lancet. Lung cancer: some progress, but still a lot more to do. Lancet. 2019 Nov 23;394(10212):1880. doi: 10.1016/S0140-6736(19)32795-3. PMID: 31777378.
Copy Download .nbib Format: NLM
Failure to identify association between deprivation and incidence of lung cancer surprising.

Journal of epidemiology and community health

Adams J, Battersby J, Flowers J, Harvey I.
PMID: 15831696
J Epidemiol Community Health. 2005 May;59(5):434; author reply 434.

No abstract available.

Cite
Adams J, Battersby J, Flowers J, et al. Failure to identify association between deprivation and incidence of lung cancer surprising. J Epidemiol Community Health. 2005;59(5):434; author reply 434
Adams, J., Battersby, J., Flowers, J., & Harvey, I. (2005). Failure to identify association between deprivation and incidence of lung cancer surprising. Journal of epidemiology and community health, 59(5), 434; author reply 434.
Adams, J, et al. "Failure to identify association between deprivation and incidence of lung cancer surprising." Journal of epidemiology and community health vol. 59,5 (2005): 434; author reply 434.
Adams J, Battersby J, Flowers J, Harvey I. Failure to identify association between deprivation and incidence of lung cancer surprising. J Epidemiol Community Health. 2005 May;59(5):434; author reply 434. PMID: 15831696; PMCID: PMC1733075.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries